Suzuken Co., Ltd. (SZUKF)
30.30
0.00 (0.00%)
USD |
OTCM |
Dec 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 2.103B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 2.22% |
| Valuation | |
| PE Ratio | 10.81 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.1355 |
| Price to Book Value | 0.766 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.3346 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0573 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 8.15% |
Profile
| Suzuken Co., Ltd. engages in the pharmaceutical business. It operates through the following segments: Pharmaceutical Wholesale, Pharmaceutical Manufacturing, Insurance Pharmacy, and Healthcare-related Services. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic reagents, medical equipment, and supplies. The Pharmaceutical Manufacturing segment manufactures and sells pharmaceuticals and diagnostic reagents. The Insurance Pharmacy segment prepares medicines based on prescriptions from medical institutions. The Healthcare-related Services segment includes medical book sales, medical device manufacturing, and drug transportation businesses. The company was founded by Kenzo Suzuki on November 13, 1932 and is headquartered in Nagoya, Japan. |
| URL | http://www.suzuken.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | Aichi |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Next Earnings Release | Feb. 12, 2026 (est.) |
| Last Earnings Release | Nov. 13, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 30, 2025 |
Ratings
Profile
| Suzuken Co., Ltd. engages in the pharmaceutical business. It operates through the following segments: Pharmaceutical Wholesale, Pharmaceutical Manufacturing, Insurance Pharmacy, and Healthcare-related Services. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic reagents, medical equipment, and supplies. The Pharmaceutical Manufacturing segment manufactures and sells pharmaceuticals and diagnostic reagents. The Insurance Pharmacy segment prepares medicines based on prescriptions from medical institutions. The Healthcare-related Services segment includes medical book sales, medical device manufacturing, and drug transportation businesses. The company was founded by Kenzo Suzuki on November 13, 1932 and is headquartered in Nagoya, Japan. |
| URL | http://www.suzuken.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | Aichi |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Next Earnings Release | Feb. 12, 2026 (est.) |
| Last Earnings Release | Nov. 13, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 30, 2025 |